Brief: BPH Global Says Sources Bird's Nest Products From China National Pharmaceutical Group
June 6 (Reuters) - BPH Global BP8.AX :
* SOURCES BIRD'S NEST PRODUCTS FROM CHINA NATIONAL
PHARMACEUTICAL
GROUP
* UNIT ENTERED INTO FRAMEWORK SUPPLY AGREEMENT WITH
GUANGZHOU
XIAOLIWU BIOTECHNOLOGY
* AGREEMENT FOR SUPPLY OF BIRD'S NEST PRODUCTS TO FOSHAN
GEDISHI
FOR ON-SALE INTO CHINESE MARKET
Further company coverage: BP8.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For